Wipro introduces regulatory literature monitoring for pharmaceutical organizations

Wipro has introduced regulatory literature monitoring for pharmaceutical organizations by entering a managed services engagement with Springer Nature.

Drug safety, referred to as Pharmacovigilance (PV), constitutes the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. PV departments in Life Sciences organizations, to fulfil drug safety requirements, leverage literature monitoring that includes Annual Reports, Periodic Safety Update Reports, Individual Case Study Report (ICSR) Monitoring, among others

Powered by Capital Market - Live News